Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • influenza

Tag: influenza

  • BiotechToday
  • World

Diallyl Trisulfide: A potent antiviral against H9N2 Influenza

BioTech Today August 26, 2021August 26, 2021

Shayan Ahmed, Jamia Millia Islamia, New Delhi Influenza is a serious respiratory infection that causes a significant amount of morbidity and mortality. Annually, it is estimated that 290,000–650,000 people die from influenza. There are currently two kinds of anti-influenza virus therapeutic options: M2 channel blockers and neuraminidase inhibitors. However, the clinical utility of these medicines […]

Read More
  • BiotechToday
  • World

Meningitis- creating bacteria: Weapons to destroy our immune system

bioxone May 12, 2021May 11, 2021

Ayooshi Mitra, Amity University Kolkata Meningitis is an inflammatory condition that affects the membranes that surround the brain and spinal cord. Viruses, bacteria, fungi, and parasites can all cause it. Bacterial meningitis is one of the most serious types, and it is a leading cause of death and disability in children all over the world. […]

Read More
  • BiotechToday
  • World

Seasonal influenza A virus (IAV) vaccines with High-Affinity Antibodies

bioxone January 11, 2021January 11, 2021 1

Thota Kanishka Rao, Amity University Kolkata Improving the age of comprehensively receptive antibodies against influenza A virus (IAV) is a pertinent objective toward building up a global IAV immunization. While antibodies that bind conserved IAV epitopes have been recognized in people, antibodies specific for the variable epitopes are substantially more predominant than antibodies perceiving conserved […]

Read More
  • BiotechToday
  • World

An aid to the pandemic: Development of the low-cost, highly efficient ventilator by UK scientists

bioxone January 6, 2021January 6, 2021 1

Ayooshi Mitra, Amity University, Kolkata A small but important aspect of managing a pandemic virus infection that affects the lungs, including SARS-CoV-1, SARS-CoV-2 (COVID-19), and influenza, is mechanical ventilation. Generally, ventilators are costly, difficult to maintain, and need considerable training to use. The majority of ventilators rely on high-flow oxygen and medically pure compressed air […]

Read More
  • BiotechToday
  • World

Early Response to Influenza Virus in Dendritic Cells

bioxone October 30, 2020October 29, 2020

Thota Kanishka Rao, Amity University Kolkata The influenza infection is related to significant trouble in the human population especially associated with specific danger to kids, the older, and those with certain ailments, for example, pregnancy, obesity, or metabolic disease. Disease with the flu infection triggers a natural immune response pointed toward starting the versatile reaction […]

Read More
  • BiotechToday
  • World

New model analyzing viral mechanisms- a potential new chapter in viral disease treatment

bioxone October 11, 2020October 10, 2020

-Sampriti Roy, Asutosh College, University of Calcutta. “As a result of this unique human viral expression system based on stem cells, it will now be possible to simulate a large number of diseases in their progression and, for the first time, analyse them with the utmost precision”, said Guiscard Seebohm, delighted at the success of […]

Read More
  • BiotechToday
  • India
  • World

COVID-19 or flu? Which one to control first?

bioxone October 7, 2020October 7, 2020

Camelia Bhattacharyya, Amity University Kolkata Amidst the pandemic prevailing recently due to the SARS-CoV-2, there is something which still can’t be ignored, the flu which leads to thousands of deaths in the US and infects about 11% of the population each year according to CDC. With the arrival of the flu along with the COVID-19, […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy